secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001558370-23-017235
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q3 net sales up 10% to $78M; raises FY2023 guidance to $307-310M
------------------------------------------------------------------------

- Net sales $78.0M (+10% YoY); glaucoma $58.3M (+9%), corneal health $19.7M (+12%).
- GAAP net loss $30.4M ($0.63/share); non-GAAP net loss $24.2M ($0.50/share).
- Raised FY2023 net sales guidance to $307-310M from $304-308M.
- Cash and equivalents $307M at quarter end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000155837023017235/0001558370-23-017235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000155837023017235/gkos-20231101x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-017235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer